Moxifloxacin Clinical Trials
7 recruitingDrug
Phase 34Phase 23Phase 12
Showing 1–7 of 7 trials
Recruiting
Phase 3
Shortened Regimen for Drug-susceptible TB in Children
TuberculosisTuberculosis, PulmonaryMycobacterium Tuberculosis+1 more
Johns Hopkins University860 enrolled9 locationsNCT06253715
Recruiting
Phase 1
A Study to Evaluate the Effect of BMS-986278 on Cardiac Repolarization in Healthy Participants
Healthy Volunteers
Bristol-Myers Squibb32 enrolled1 locationNCT07422298
Recruiting
Phase 2Phase 3
Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR
University of California, San Francisco400 enrolled6 locationsNCT06441006
Recruiting
Phase 1
A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.
Healthy VolunteersCardiac Repolarization
Sanofi44 enrolled2 locationsNCT07272629
Recruiting
Phase 2
PanACEA - STEP2C -01
Pulmonary TuberculosisOther Specified Pulmonary Tuberculosis
Michael Hoelscher390 enrolled10 locationsNCT05807399
Recruiting
Phase 2Phase 3
Finding the Optimal Regimen for Mycobacterium Abscessus Treatment
Pulmonary Disease Due to Mycobacteria (Diagnosis)
The University of Queensland300 enrolled50 locationsNCT04310930
Recruiting
Phase 3
A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP
Community-acquired Bacterial Pneumonia
Zai Lab (Hong Kong), Ltd.100 enrolled40 locationsNCT06162286